A structured teaching and self-management program for patients receiving oral anticoagulation. A randomized controlled trial

JAMA

Volumn 281, Issue 2, 1999, Pages 145-150

  Sawicki, Peter T ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; EDUCATION PROGRAM; FEMALE; HOME MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PRIORITY JOURNAL; PROTHROMBIN TIME; QUALITY OF LIFE; RISK ASSESSMENT; SELF MEDICATION; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0033550473     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.2.145     Document Type: Article

References (26)

1. Hirsch J. Drug therapy: oral anticoagulant drugs. N Engl J Med. 1991;324:1865-1875.
2. Rosendaal FR. The scylla and charybdis of oral anticoagulant treatment. N Engl J Med. 1996;335:587-589.
3. Saour JN, Sieck JO, Mamo LAR, Gallus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med. 1990;322:428-432.
4. Standing Advisory Committee for Haematology of the Royal College of Pathologists. Drug interactions with coumarin derivate anticoagulants. BMJ. 1982; 285:274-275.
5. Paterson CE, Kwaan HC. Current concepts of warfarin therapy. Arch Intern Med. 1986;146:581-584.
6. Kumar S, Haigh JRM, Rhodes LE, et al. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost. 1989; 62:729-732.
7. Mühlhauser I, Berger M. Diabetes education and insulin therapy: when will they ever learn? J Intern Med. 1993;233:321-326.
8. Sawicki PT, Mühlhauser I, Didjurgeit U, Baumgarttier A, Bender R, Berger M. Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy. J Hypertens. 1995;13:933-938.
9. Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L. Long-term patients' self-management of oral anticoagulation. Arch Intern Med. 1995;155:2185-2189.
10. Ansell JE, Holden A, Knapie N. Patients' self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times. Arch Intern Med. 1989;149:2509-2511.
11. Ad Hoc Committee of the Working Group on Valvular Disease, European Society of Cardiology. Guidelines for prevention of thromboembolic events in valvular heart disease. J Heart Valve Dis. 1993;2:398-410.
12. van den Besselaar AMHP, Breddin K, Parker-Williams J, et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagul Fibrinolysis. 1995;6:726-732.
13. Todd C, Bradley C. Evaluating the design and development of psychological scales. In: Bradley C, ed. Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Newark, NJ: Harwood Academic Publishers; 1994:15-42.
14. Landefeld CS, Anderson PA, Goodnough LT, et al. The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy. J Clin Epidemiol. 1989; 42:711-718.
15. Koch GG, Landis JR, Freeman JL, Freeman DH Jr, Lehnen RG. A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics. 1977;33:133-158.
16. SAS Institute Inc. SAS/STAT, Version 6: A Guide for Personal Computers. Cary, NC: SAS Institute Inc; 1987.
17. White RH, McCurdy SA, von Marensdorf H, Woodruff DE, Leftgoff L. Home prothrombin time monitoring after initiation of warfarin therapy. Ann Intern Med. 1989;111:730-737.
18. Anderson D, Harrison L, Hirsch J. Evaluation of a portable prothrombin time monitor for home use by the patients who require long-term oral anticoagulant therapy. Arch Intern Med. 1993;153:1441-1447.
19. Bernardo A, Halhuber C, Horstkotte D. Home prothrombin estimation. In: Butchart EG, Bodnar E, eds. Thrombosis, Embolism and Bleeding. London, England: ICR Publishers; 1992:325-330.
20. Massicotte P, Marzinotto V, Adams M, Andrew M. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J Pediatr. 1995;127:389-394.
21. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis. ISH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemost. 1985;53:155-156.
22. Duxbury BD. Therapeutic control of anticoagulant treatment. BMJ. 1982;284:702-704.
23. Harries AD, Birtwell AJ, Jones DB. Anticoagulant control. Lancet. 1981;1:1320.
24. Schulman S. Quality of oral anticoagulant control and treatment in Sweden. J Int Med. 1994;234: 143-152.
25. Landefeld CS, Goldman L. Major bleeding in out-patients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87:144-152.
26. Kitchen S, Walker ID, Woods TA, Preston FE. Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Thromb Haemost. 1994;72:426-429.